AXMP AXM Pharma Inc (CE)

AXM Pharma Inc. (OTC: AXMP) a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian markets, announced today that it has hired four experienced Chinese pharmaceutical sales and marketing employees to lead its sales activities in 2007. The Company appointed Wang Wenxiu as General Manager of AXM Pharma (Shenyang), Inc., Mei Shengliang, General Manager of Sales & Marketing, Han Aiguo as Vice General Manager and Jiao Yu, Vice General Manager. �We are excited to attract such an experienced and talented team of marketing executives,� said Wang Weishi, president and CEO of AXM Pharma, Inc. �These executives should help us achieve our 2007 sales objectives.� Prior to joining AXM, Mr. Wang Wenxiu joined Jilin Tonghua Tianma Pharma Limited Company in 2000, and served as marketing general manager for five years. From the end of 2005 till the end of 2006, he served as General manager in Beijing Yuhuatang Sci-Tech Development Co., Ltd. Mr. Mei Shengliang graduated in 1986 from Nanjing University of Traditional Chinese Medicine (TCM). From 1986 through 1999, he served in various capacities, including distribution manager for Jiangsu Yangtse River Pharmaceutical Group nationwide. Mr. Mei served as General Manager of Jiangsu Jichuan Pharma Inc from 1999 until 2003, and Senior General Manager in Shenzhen Wanji Group from 2004 through 2005. Thereafter, he was General Manager of Hainan Zhongshengkang Medicine Co., Ltd. Prior to joining AXM Pharma (Shenyang), Inc., Mr. Han Aiguo served in Jilin AoDong Medicine Industry Group Co., Ltd (AoDong) for 14 years (from 1992 to 2006). AoDong was founded in 1993 and became a Shenzhen Stock Exchange (SSE) listed company in October, 1996. In 1999, Mr. Han was entrusted by AoDong to establish Zhengzhou (capital of Henan province) AoDong Pharma Ltd, a subsidiary of AoDong engaged in. From 1999 to 2006, Mr. Jiao Yu served in Jinlin Tonghua Tianma Pharma Limited Company as Regional Manager and Guangdong Hefeng Pharma Ltd as Vice General Manager. About AXM Pharma, Inc. AXM Pharma, Inc., through its wholly owned subsidiary, AXM Pharma Shenyang, Inc. ("AXM Shenyang"), is a manufacturer of proprietary and generic pharmaceutical products, which include injectables, capsules, tablets, liquids and medicated skin products for export and domestic Chinese sales. AXM Shenyang is located in the City of Shenyang, in the Province of Liaoning, China. AXM Shenyang has an operating history of approximately 10 years. For additional information on AXM Pharma Inc., please visit http://www.axmpharma.com Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this news release include certain predictions and projections that may be considered forward-looking statements under securities law, including the statements regarding the Company's opportunities for future growth. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, obtaining regulatory approvals to market the Company's products, the uncertainties associated with distributing products in a developing country such as China, the availability of cash to meet near term requirements as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products and prices. With respect to AXM, except for the historical information contained herein, the matters discussed in this news release are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, AXM's extremely limited operating history, uncertainties related to the Company's access to additional capital, competition and dependence on key management.